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Summary
Objectives: To evaluate the acceptability, feasibility and performance of a mammography screening programme for
female patients in general practice. Design: A cross sectional study. Setting: A general practice clinic and a resiona/
hospital in Hong Kong. Subjects: 500 Chinese women aged 45 years or older attending a university teaching general
practice clinic on Hong Kong Island. Main outcome measures: The rates of uptake of screening, retakes, recall for further
evaluation and fine needle aspiration (FNA), and participants' opinion on mammography. Results: The uptake rate of
screening was 37%. Mammography was feasible for all participants, 12% had additional films and 7% required retakes.
Sixteen percent were recalled for further evaluation, 4% had FNA, one had an excisional biopsy which revealed no
cancer. Most women rated pain of mammography mild to moderate and did not find it embarrassing, 98% said that they
would recommend it to their friends and 87% indicated that they would do it again. Conclusions: Mammography
screening for Chinese women presenting to general practice was technically feasible. Most women found the experience
of mammography screening acceptable. The uptake rate of mammography screening was much lower than what would
be required to benefit the overall breast cancer mortality. There was also room for improvement in our retake and recall
rates. We need to weigh the possible benefit of mammography screening against the stress and resources associated
with additional films, retakes, recalls for further evaluation, FNA and excisional biopsy in individuals with false positive
results. (HKPract 1996; 18: 315-320)
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Introduction
Breast cancer is the second most
common cancer and cause of cancer
death in women in Hong Kong.1-2
There were 333 deaths and 1106
new cases of breast cancers in
women in Hong Kong in 1991.2 A
woman in Hong Kong has about one
in 27 chance of having breast cancer
and one in 100 chance of dying from
it during her average life of 80.5
years. Although these rates are lower
than the one in 8 morbidity and one
in 28 mortality in American women,3
their steadily rising trend is a cause for
concern.1
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The other cause for concern is that
most of our breast cancers are stage II
or more when they are diagnosed.4
The prognosis of breast cancers
depends on the stage of the tumour.
The 5 year survival rate of stage II
cancers is only 71%, that of stage I
cancers is 84% while that of ductal
carcinoma in-situ is 98%.5-6
Mammography can detect in-situ
cancers and early stage I cancers
which have better survivals.7'9
Several large clinical trials have
shown that regular mammography
screening can reduce breast cancer
deaths in women aged 50 to 74 by
about 30%.7'8-10'13 Regular mammo-
graphy screening for women over the
age of 50 years is recommended in
many Western countries.10-14"16
Many studies on mammography
screening7'8-10'13 use cancer detection
rate as the outcome indicator which
is important on a population basis,
but the chance of a general
practitioner detecting a breast cancer
by mammography among his/her one
thousand or so female patients is
very low. General practitioners more
commonly have to deal with making
the test available to the target
population, giving information about
the procedure before screening,
following up results, counselling
women who require further
evaluation, co-ordinating further
evaluation, and making referral for
appropriate treatment.16 They need
information on patients' acceptability
of the test, quality of local
mammography service, chances of
recalls and fine needle aspiration
(FNA), but there is very little local
data on these. Most local data on
mammography come from specialist
clinics on selected groups of patients
which may not be applicable to
women seen in general practice.4-17
This is a pilot study to evaluate the
uptake rate, feasibility, patient
acceptability and performance of a
screening mammography programme
for patients in general practice in
Hong Kong. We used the rates of
retakes, recall for further evaluation,
FNA, and excisional biopsy as our
performance indicators. These are
commonly used to assess the quality
of mammography screening
programmes.10-18'19 We hope the
information will help general
practitioners counsel their patients
and plan their services on screening
mammosraphy better.
Methods and subjects
All women aged 45 years and
older attending the general practice
clinic of the General Practice Unit, the
University of Hong Kong, from
December 8, 1992 to May 30, 1993
were invited to take part in the study.
A trained interviewer explained to
each eligible woman about the
objectives of the study and the
procedure of screening mammo-
graphy. Those who agreed to take
part then answered a structured
questionnaire on their demography,
previous experience of breast cancer
screening and risk factors for breast
cancer.20-21 Each participant was then
given an appointment for
mammography at the Department of
Diagnostic Radiology, Queen Mary
Hospital about 5 kilometres from the
clinic. The interviewer called each
participant to remind her of the test
one or two days before the
appointment.
The mammographies were taken
by radiographers with special training
in mammography under the
supervision of a radiologist
specialised in mammography. The
machine used was a GE Senographe
600T dedicated mammographic unit.
Each breast had two standard, the
cranial-caudal and medio-lateral
oblique views. Normally one film
was taken per view per breast but
additional films might be necessary
for complete imaging of the breasts.
Retakes were done if the films were
of poor quality due to technical
problems.
All mammographies were read
by the radiologist (Ho) and the
reports were returned to the General
Practice Unit. Each participant was
followed up at the General Practice
Unit for result and an interview on
her opinion of the test. Those who
needed further evaluation were
given appointments to attend the
multidisciplinary mammography clinic
at Queen Mary Hospital. All woman
recalled for further evaluation were
examined by the surgeon. Some had
additional mammography, ultrasono-
graphy or both as indicated. Fine
needle aspiration was performed for
suspicious lesions found on further
evaluation.
The study protocol was
approved by the Ethics Committee,
Faculty of Medicine, The University of
Hong Kong.
All the data were analysed using
the SPSS-PC + computer programme.29
Results
Sample
Five hundred women aged 45
years or older were invited to take
part in mammography screening, 221
initially agreed but only 184 (37%)
eventually turned up for the test. The
data of one woman were incomplete
and she was excluded from further
analysis. The final sample for further
analysis was 183.
The mean age of the 183 women
screened was 59.5 (S.D.=9.5) years,
ranging from 45 to 88. The
distribution of the sample by age,
education, social class by
occupation,23 and possible risk
factors for breast cancer is shown in
(Table 1).
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Table 1: Distribution of sample by demography and risk factors for breast
Proportion of sample (%)
(n=1S3)
(yr)"
Social class
Age at menarche
(yr)
at menopause
-(yr)
45-49
50-70
>70 j;;; ', -
'"Nil ?"'" ^ "" ' '",
Primary
Secondary
Tertiary
I, II & n
IV &V
12 or less "';' :,"*..""
•'13-21.. •*" . -•• -;••:';
Not remembered
50 or more
< 5 o ^ . : • ;
Pre-menopause
Had hysterectomies
Nulliparity
first birth >29 yrs old
Never,
1-36 :
37-1 O8
>108
Unsure
Benign
Unsure nature
None
Yes
No
Not sure
' percentages do not add up to 100 because of rounding.',
Parity
Cumultative duration
of breast feeding
(month)
History of breast disease
', family history of
breast disease
19
67
14
44
39
15
3,.,,
17
83
7':::
85:
8
40
34
1.6io
8
7
22
33"
36
8
1
14-
2
84-
4
94
Thirty percent of the women had
heard of mammography and 3 women
had the test before. Thirty seven
percent had had breast examination by
a doctor before. Nineteen percent
had been tausht breast self
examination (BSE) and 18% had ever
practised it.
Feasibility and accept-
ability
The programme ran smoothly
with patient recruitment,
appointments for mammographies
and further evaluation, and follow up
of results of investigations were
coordinated in the general practice
clinic. The parenchymal patterns of
the breasts of our women were
found to be suitable for screening
mammography. The mammographic
patterns of our women will be
discussed in greater details in
another paper.
Women were asked about their
opinion of mammography after they
had the test. (Table 2) shows the
distribution of the level of pain of
mammography rated on a scale of O
(no pain at all) to 5 (the worst pain)
by the women. Two third of them
rated the pain as 2 or less. Eighty-
seven percent of them did not find
the test embarrassing at all, 13%
found it moderately and only one
person found it very embarrassing.
Ninety-eight percent of them said
that they would recommend
mammography screening to their
friends and 87% of them indicated
that they were willing to repeat the
screening regularly.
Performance of the
screening programme
Twelve (7%) required retakes
because of technical problems.
Twenty- two (12%) women required
additional films because of large
breasts in 18, and difficulties in
positioning in two very thin patients
and two patients with deformed
nipples.
Twenty nine (16%) women were
recalled for further evaluation for
suspicious mammographic findings as
shown in (Table 3). Two women with
breast asymmetry refused further
evaluation. The remaining 27 women
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all had breast examination by the
surgeon, 10 had additional mammo-
graphies, 11 had additional mammo-
graphies and ultrasonographies, and
three had ultrasonographies only.
Further evaluation found some
abnormalities in 10 and no
abnormality in 17 of these 27
patients (Table 3).
Among the 10 patients with some
abnormalities on further evaluation,
the surgeon could feel lumps in the
breasts of seven of them. All these 7
patients with palpable lumps had
FNA which showed benign cells in
four, insufficient cells for diagnosis in
two and atypical cells in one. The
patient who had atypical cells on
FNA had an excisional biopsy which
showed fibrocystic disease. The
remaining three patients had benign
masses on additional mammographies
but no mass was felt on physical
examination. They had ultrasono-
graphies which showed no lesion in
two and a 1 cm benign mass in one.
FNA was not done on these three
patients. All ten patients with
abnormalities on further evaluation
were referred to the specialist Breast
Clinic for continual follow up.
Table 2: Pain of mammography rated by subjects
Level of pain
0 (no-pain
1 . .'.",.
2
3
4 >., .;• ••• ;•.
5 (worst pain)
Number of women (n=183)
::
-"•".;;•• 6 ::;'";
'';, ! / 64 -:: •
53
33
;;•'...:.. 19 ;;;• ' . ' , .•
; • • • ' " • ' ; 8 ."-•-"- ' :
Table 3: Indications and outcomes of further evaluation
Outcomes of further
Indications for recall No abnormalities
!
 found """?-•"•
Abnormalities
found done
Breast asymmetries (n=13)
Mass (n=11)
Breast asymmetries and mass (n=
Skin changes (n=1) """;:;: ! . *
Axillary mass (n=1) "'-
11
4
2
4
•-Q:
Discussion
The main limitation of our study was
the small sample size. On the other
hand, this is likely to be the number
that an average general practice deals
with. We believe that our findings may
be applicable to other women of
similar age, educational level and social
status in Hong Kong. The distribution
of the education levels of our sample
was similar to that of the general
population.24 The majority of our
sample came from the lower socio-
economic groups, which is also the
case for females aged 45 years or
more in the general population.24
The uptake rate of screening of
37% was much lower than the 70%
considered to be necessary for
improving the breast cancer death
rates.7-18 '19 The screening was
offered to women free of charge, the
response rate might even be lower
if they had to pay. The low response
rate might be due to a general lack
of awareness of breast cancer
screening in our population. Only
30% of the sample had ever heard
of mammography, 37% had ever had
their breasts examined by a doctor
and only 18% had ever examined
their own breasts. Women gave a
variety of reasons for refusing the test
which would be the subject for
discussion in another paper.
The encouraging finding was that
most participants found mammo-
graphy acceptable after they had
done it. Very few found the test very
painful or embarrassing. Over 90%
said that they would recommend it
to their friends and 87% said that
they were willing to repeat the
screening. It seems that if we can
motivate women to have the first
screening, they may continue and
motivate others to take part.
The breasts of our women were
suitable for mammography as
suggested by Cheung.4 This was
318
Hong Kong Practitioner 18 (7) July 1996
•for-
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against the resources and
different from the findins of a local
study in 1985 that the breasts of
Chinese women were too small for
mammography.17 The quality of the
mammography equipment has
improved since 1985. Furthermore,
the women were much younger
(median age 46 years old) and the
mammographies were done for
diagnosis rather than screening in this
early study.17
The retake rate was slightly higher
than the international standard of less
than 5%.19-25 This may improve with
more experience. More than 10%
women required additional films.
Patients should be informed before
the test of the possibility of
additional films or retakes and be
reassured that the amount of
radiation from modern mammo-
graphy machines is quite negligible26
to avoid unnecessary anxiety.
Fifteen percent, that is, one in
six of the women required further
evaluation. Fortunately or
unfortunately, none had breast
cancer. Our recall rate was twice
that of some other screening
programmes.10'18'27 We took the
more conservative approach of
recalling all women with breast
asymmetry for further evaluation
because the lack of local data on its
significance. It turned out that most
breast asymmetries did not have any
abnormality on further evaluation.
The threshold for recall is a trade-off
between false positives and false
negatives.28 Recalls for further
evaluation could be very stressful for
patients who may be particularly
frustrated by false positive results.28'30
Cockburn et al showed that women
recalled for further evaluation
showed significantly more emotional
and physical dysfunction, which
were still present one week after
they were told of their normal
results.30 More local experience in
mammography may improve the
predictive accuracy and reduce the
recall rate. However, false positive
recall is an inevitable part of any
screening programme and is always
more common than true positives.28
General practitioners must be aware
of this and be prepared to counsel
patients before and after their further
evaluation.
The FNA rate in our study was 4%
which was comparable to those of
other programmes.10-18-27 It was not
surprising that we did not detect any
breast cancer in the 183 women
screened. The expected cancer
detection rate is 5-8/1000 in western
populations10-18'27 and it may even be
lower locally.4
Conclusions
We found that mammography
screening for patients presenting to
general practice was technically
feasible and breasts of our women
were suitable for mammography.
Most women found the experience
of mammography acceptable. Our
FNA rate was comparable to those
of screening programmes in other
countries but there is room for
improvement in our screening
uptake, retake and recall rates.
We now have more information
about mammography for our female
patients in general practice. We can
reassure them that most women only
experience mild pain from the test
and the chance of finding a cancer
is quite low. On the other hand, we
need to prepare them psycho-
logically for a one in five chance of
additional films or retakes, one in six
chance of recall for further evaluation
and one in 26 chance of having a fine
needle aspiration. All these will have
to be weighed against the possible
benefit of mammography screening.
The very low uptake rate of
screening shows that most of our
women in general practice are not
willing to have mammography
screening. We are unlikely to have
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any significant reduction in our breast
cancer mortality if only 37% of the
target population were willing to be
screened. A more cost-effective
approach may be to target women
in the high risk group e.g. previous
breast cancer or positive family history,
who may be more aware of the
problem and thus more motivated to
screening. More public education to
raise the general awareness of breast
cancer and mammography may also
help to improve the uptake rate of
screening.
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